Patient interviews | N = 26 |
 Age |  |
  Median years (range) | 62 (42–75) |
 Sex |  |
  Females/males | 14/12 |
 Index of multiple deprivation decilea |  |
  Most deprived (1–3) | 4 |
  Average deprivation (4–7) | 11 |
  Least deprived (8–10) | 8 |
 Format of interview |  |
  Telephone | 26 |
 Duration of interview |  |
  Median minutes (range) | 61 (40–84) |
 PETReA trial participation status |  |
  Consent (v declined) | 25 (v 1) |
 PET-CT response to induction and trial arm allocationb | n = 25 |
  Complete metabolic response (CR) |  |
   No further treatment | 9 |
   Maintenance | 8 |
  Partial response (PR) |  |
   Maintenance | 4 |
   Maintenance plus Lenalidomide | 4 |
 No. of participating UK sites | 12 |
Practitioner interviews | N = 15 |
 Practitioner’s role |  |
  Haematologist oncologist | 10 |
  Research nurses/clinical trial practitionersc | 5 |
 Format of interview |  |
  Telephone | 11 |
  Face-to-face | 3 |
  Video call | 1 |
 Duration of interview |  |
  Median minutes (range) | 62 (32–81) |
 No. of participating UK sites | 12 |
Total interviews | 41 |
 No. of participating UK sites | 16 |